| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/29/2002 | WO2002066622A2 Method of generating diversity into lipolytic enzymes and lipolytic enzyme genes |
| 08/29/2002 | WO2002066621A1 Attenuated live vaccine |
| 08/29/2002 | WO2002066620A2 Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system |
| 08/29/2002 | WO2002066618A1 Rapid production of monoclonal antibodies |
| 08/29/2002 | WO2002066617A1 Method for detecting a risk of hypertension and uses thereof |
| 08/29/2002 | WO2002066616A2 Engineering fungi for the utilisation of l-arabinose |
| 08/29/2002 | WO2002066615A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 08/29/2002 | WO2002066614A2 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 08/29/2002 | WO2002066613A2 Novel ecdysone receptor/invertebrate retinoid x receptor-based inducible gene expression system |
| 08/29/2002 | WO2002066612A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 08/29/2002 | WO2002066611A2 Minimal plasmid vectors that provide for persistent and high level gene expression and methods for using the same |
| 08/29/2002 | WO2002066601A2 Polynucleotide encoding a novel human potassium channel beta-subunit, k+betam2 |
| 08/29/2002 | WO2002066599A2 Efficient method for the development of transgenic plants by gene manipulation |
| 08/29/2002 | WO2002066514A2 Artificial fusion proteins with reduced immunogenicity |
| 08/29/2002 | WO2002066513A2 Human circulating lekti fragments hf7072, hf7638 and hf14448 and use thereof |
| 08/29/2002 | WO2002066512A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/29/2002 | WO2002066509A2 Treatment involving dkk-1 or antagonists thereof |
| 08/29/2002 | WO2002066507A2 Histidine phosphatase interacting protein of 120 kd |
| 08/29/2002 | WO2002066505A2 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof |
| 08/29/2002 | WO2002066504A2 Protein-protein interactions in saccharomyces cerevisiae |
| 08/29/2002 | WO2002066503A2 H. influenzae antigen basb213 |
| 08/29/2002 | WO2002066501A2 PROTEIN-PROTEIN INTERACTIONS IN $i(HELICOBACTER PYLORI) |
| 08/29/2002 | WO2002066494A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 08/29/2002 | WO2002066135A1 A microchip electrospray device and column with affinity adsorbents and use of the same |
| 08/29/2002 | WO2002066071A2 Treatment of tissue fibrosis by blocking the sp1 transcription factor |
| 08/29/2002 | WO2002066070A1 Pharmaceutical compositions containing decoy and method of using the same |
| 08/29/2002 | WO2002066058A1 Modified anti-egfr antibodies with reduced immunogenicity |
| 08/29/2002 | WO2002066054A1 Vaccine to protect animals against leishmania |
| 08/29/2002 | WO2002066012A2 Amphoteric liposomes and the use thereof |
| 08/29/2002 | WO2002065990A2 A COMPOSITION AND METHOD FOR RECONSTITUTING I$G(K)B KINASE IN YEAST AND METHODS OF USING SAME |
| 08/29/2002 | WO2002065943A2 Ocular tear growth factor-like protein |
| 08/29/2002 | WO2002052025A3 Plant transformation process with selection and early identification of germline events |
| 08/29/2002 | WO2002048676A3 Multiple array system for integrating bioarrays |
| 08/29/2002 | WO2002042316A3 Pna analogues |
| 08/29/2002 | WO2002041836A3 Antisense modulation of src-1 expression |
| 08/29/2002 | WO2002038759A3 Method for inducing apoptiosis |
| 08/29/2002 | WO2002036787A3 Herbicide-tolerant plants through bypassing metabolic pathway |
| 08/29/2002 | WO2002034930A3 Methods of use of regulators of g-protein signaling to modulate dopamine signaling and dopamine-related neurobehavior |
| 08/29/2002 | WO2002022795A3 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 08/29/2002 | WO2002020797A3 Genes encoding polypeptides from methylomonas sp. involved exopolysaccharide production |
| 08/29/2002 | WO2002020786A3 Kinase d interacting protein |
| 08/29/2002 | WO2002020737A3 Genome engineering by cell-permeable dna site-specific recombinases |
| 08/29/2002 | WO2002020723A3 Compositions and methods for targeting peptides in humans in vivo |
| 08/29/2002 | WO2002016426A3 Coaster, a human coactivator of steroid receptors |
| 08/29/2002 | WO2002016396A8 Mammalian rh type b glycoprotein ion transporter |
| 08/29/2002 | WO2002010403A3 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 08/29/2002 | WO2002010388A3 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 08/29/2002 | WO2002008408A3 Modular vector systems |
| 08/29/2002 | WO2002006320A3 Method for influencing the content of sinapine in transgenic plant cells and plants |
| 08/29/2002 | WO2002004649A3 Methods for enhancing plant transformation frequencies |
| 08/29/2002 | WO2002004630A3 Methods for recombinatorial nucleic acid synthesis |
| 08/29/2002 | WO2002004629A3 Molecular breeding of transposable elements |
| 08/29/2002 | WO2002002774A3 32626, a human udp-glycosyltransferase and uses thereof |
| 08/29/2002 | WO2002000836A3 Spinigerin variants, an antibacterial and antifungal peptide derived from pseudacanthotermes spiniger, preparation method and compositions containing same |
| 08/29/2002 | WO2001096547A3 Human kinases |
| 08/29/2002 | WO2001094394A3 Plant ubiquitin promoter sequences and methods of use |
| 08/29/2002 | WO2001094388A3 Zcys6: a member of the cystatin superfamily |
| 08/29/2002 | WO2001092493A3 21956 and 25856, human aminopeptidases and uses thereof |
| 08/29/2002 | WO2001090343A3 Nucleotide sequences encoding ramosa 1 gene and methods of use for same |
| 08/29/2002 | WO2001088135A3 G-protein coupled receptor proteins and nucleic acids encoding same |
| 08/29/2002 | WO2001087930A3 Human galanin receptor-like g protein coupled receptor |
| 08/29/2002 | WO2001085971A3 Transgenic plants incorporating_genes of zostera marina |
| 08/29/2002 | WO2001085952A3 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof |
| 08/29/2002 | WO2001085944A3 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 08/29/2002 | WO2001083769A3 Crystallization of 4-diphosphocytidyl-2-c-methylerythritol synthesis |
| 08/29/2002 | WO2001083751A3 Methods for binding an exogenous molecule to cellular chromatin |
| 08/29/2002 | WO2001081406A3 Single-chain fertility hormones with variable lh activity |
| 08/29/2002 | WO2001079496A3 Ligand for herpes simplex virus entry mediator and methods of use |
| 08/29/2002 | WO2001079284A3 Therapeutic compounds and methods for formulating v3, a versican isoform |
| 08/29/2002 | WO2001079272A3 Sitosterolemia susceptibility gene (ssg): compositions and methods of use |
| 08/29/2002 | WO2001077355A3 Signal transduction stress-related proteins and use in plants |
| 08/29/2002 | WO2001077338A3 Human protein kinases and protein kinase-like enzymes |
| 08/29/2002 | WO2001070816A3 Ecdysone receptor-based inducible gene expression system |
| 08/29/2002 | WO2001068858A3 Human g protein-coupled receptors |
| 08/29/2002 | WO2001068848A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/29/2002 | WO2001064903A3 Novel human transferase proteins and polynucleotides encoding the same |
| 08/29/2002 | WO2001062975A3 Pyrophosphorolysis activated polymerization (pap): application to allele-specific amplification and nucleic acid sequence determination |
| 08/29/2002 | WO2001062960A3 Method for detecting cytosine methylation in dna samples |
| 08/29/2002 | WO2001061055A3 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 08/29/2002 | WO2001061030A3 LIBRARIES OF OPTIMUM SUBSEQUENCE REGIONS OF mRNA AND GENOMIC DNA FOR CONTROL OF GENE EXPRESSION |
| 08/29/2002 | WO2001057206A3 Method and reagent for the inhibition of checkpoint kinase-1 (chk 1) enzyme |
| 08/29/2002 | WO2001048164A3 Modified adenylylcyclase type vi useful in gene therapy for congestive heart failure |
| 08/29/2002 | WO2001044464A9 Targeting of endosomal growth factor processing as anti-cancer therapy |
| 08/29/2002 | WO2001042462A9 Phospholipase a2 inhibitory peptides from python reticulatus |
| 08/29/2002 | WO2001027328A8 Particle analysis assay for biomolecular quantification |
| 08/29/2002 | WO2001027296A9 Regulatory region of a lipid transfer protein (ltpw1) from aleuron tissue of wheat |
| 08/29/2002 | WO2001027289A9 Recombinant proteins and peptides for endotoxin biosensors, endotoxin removal, and anti-microbial and anti-endotoxin therapeutics |
| 08/29/2002 | WO2001016174A9 Induction of cytotoxic t lymphocyte response by hla class ia restricted epitopes of mycobacterial heat shock protein 65 |
| 08/29/2002 | WO2001007481A9 Antitumor antibodies, proteins, and uses thereof |
| 08/29/2002 | WO2000072004A9 Method of determining the three-dimensional shape of a macromolecule |
| 08/29/2002 | WO2000068382A9 PrP-LIKE GENE |
| 08/29/2002 | WO2000066737A9 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY |
| 08/29/2002 | WO2000066709A9 Zymogen activation system |
| 08/29/2002 | WO2000063245A9 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant |
| 08/29/2002 | WO2000061770A9 Enhancement of the immune response for vaccine and gene therapy applications |
| 08/29/2002 | WO2000061606A9 Novel human voltage-gated potassium channel |
| 08/29/2002 | WO2000060120A9 Methods of detecting microorganism using immobilized probes |
| 08/29/2002 | WO2000058481A9 Phosphatases with improved phytase activity |
| 08/29/2002 | WO2000056866A9 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 08/29/2002 | WO2000055330A9 Polysaturated fatty acid (pufa) elongase from caenorhabditis elegans |